Find a clinical trial


If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

« Previous 12345 Next »
Viewing Page 1 of 27 | Showing Results 1 - 5 of 132

ECM Mapping: Mapping Breast Cancer and Normal Breast Tissue Extracellular Matrix Proteins and Biomolecules

Cancer cells grow within a normal and orderly tissue microenvironment by producing and secretingchemicals that serve to favorably modify their...

Steve Martinez, M.D.
  • Everett Clinic

A randomized phase II study to evaluate efficacy of T-DM1 with or without Palbociclib in the treatment of patients with metastatic HER2 positive breast cancer

Inclusion Criteria:Be informed of the investigational nature of the study and all pertinent aspects of the trialSign and provide written consent in...

Henry Kaplan, M.D.
  • Swedish Medical Center

iRISK Identifying Women at High Risk for Breast Cancer

Screening guidelines for women at average risk for breast cancer are well-established. Patients determined to be at high risk for breast cancer...

Steve Martinez, M.D.
  • Everett Clinic

SQUARE Measuring Satisfaction, Quality of Life, and Understanding After Audio Recording Encounters

The proposed study is a prospective randomized pilot study to assess the effect of providing newly diagnosed breast cancer patients with a digital...

Steve Martinez, M.D.
  • Providence Regional Cancer Partnership - Everett

A Randomized, Double-Blind, Phase III Study of Pembrolizumab versus Placebo in Combination with Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy for the Treatment of High-Risk Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2–) Breast Cancer (KEYNOTE-756)

Inclusion Criteria:•Has a localized invasive breast ductal adenocarcinoma, confirmed by the local pathologist, that includes either T1c-T2 (tumor...

Ying Zhuo, M.D.
  • Kadlec Clinic Hematology and Oncology
  • Kadlec Research
« Previous 12345 Next »
Viewing Page 1 of 27 | Showing Results 1 - 5 of 132